Variable | Mirtazapine (n = 27) | SSRIs (n = 50) | P | Sertraline (n = 32) | Paroxetine (n = 18) | P |
---|---|---|---|---|---|---|
Male patients, n (%) | 18 (66.7) | 32 (64.0) | nsc | 20 (62.5) | 12 (66.7) | nsc |
Age, mean (SD), years | 38.9 (10.5) | 40.4 (13.8) | nsa | 39.7 (13.3) | 41.7 (14.9) | nsb |
Age at onset, mean (SD), years | 38.1 (10.5) | 39.3 (13.1) | nsa | 39.0 (12.5) | 39.8 (14.5) | nsb |
Duration of illness, median [quartiles], week | 30.0 [8.0–104.0] | 20.0 [12.0–71.0] | nsa | 20.0 [8.0–58.5] | 19.0 [12.0–117.0] | nsb |
Duration of current episode, median [quartiles], week | 12.0 [7.0–40.0] | 12.0 [8.0–34.0] | nsa | 14.0 [7.3–44.0] | 12.0 [12.0–21.0] | nsb |
Depressive episodes | Â | Â | nsc | Â | Â | nsc |
 Single, n (%) | 22 (81.5) | 42 (84.0) |  | 28 (87.5) | 14 (77.8) |  |
 Recurrent, n (%)d | 5 (18.5) | 8 (16.0) |  | 4 (12.5) | 4 (22.2) |  |
Past history of using any psychiatric services, n (%) | 4 (14.8) | 15 (30.0) | nsc | 11 (34.4) | 4 (22.2) | nsc |
Past history of any psychotropic medication, n (%) | 11 (40.7) | 18 (36.0) | nsc | 14 (43.8) | 4 (22.2) | nsc |
Treatments of the current episode, n (%) | 4 (14.8) | 5 (10.0) | nsc | 5 (15.6) | 0 (0.0) | nsc |
Antidepressant treatment of the current episode, n (%) | 3 (11.1) | 3 (6.0) | nsc | 3 (9.4) | 0 (0.0) | nsc |
Benzodiazepine treatment of the current episode, n (%) | 1 (3.7) | 1 (2.0) | nsc | 1 (3.1) | 0 (0.0) | nsc |
HDRS, mean (SD) | 23.0 (5.2) | 23.1 (6.1) | nsa | 23.2 (6.2) | 22.9 (6.0) | nsb |
SDS, mean (SD) | 55.9 (5.4) | 57.9 (7.8) | nsa | 57.9 (7.4) | 57.9 (7.1) | nsb |
AIS, mean (SD) | 11.2 (3.7) | 12.9 (4.4) | nsa | 12.8 (4.3) | 13.1 (4.7) | nsb |
CGI-S, median [quartiles] | 4.0 [4.0–5.0] | 4.0 [4.0–5.0] | nsa | 4.5 [4.0–5.0] | 4.0 [4.0–5.0] | nsb |